Neomed Labs Pacific Biomarkers PAIRimmune are now Nexelis
 

search & filter

Our assay menus are offered in both alphabetical and category-based formats.

search by:

or filter by:

GIP (Gastric Inhibitory Polypeptide)

Analyte: Gastric Inhibitory Polypeptide
Specimen Type: Plasma from BD P700 or P800, EDTA Plasma with preservatives; contact nexelis for collection instructions
Optimum Volume: 0.5 mL
2-8°C -20°C -70°C
3 hours 3 days 1 year
Reporting units: pmol/L
Method: ELISA
Biological or Clinical Significance:

GIP, also known as gastric inhibitory polypeptide, or glucose-dependent insulinotropic polypeptide, is a 42 amino acid peptide hormone synthesized in and secreted from K cells in the intestinal epithelium. The gut endocrine K cells sense nutrient intake and secret GIP following ingestion of the nutrients, especially fats. Unlike GLP-1, which exerts multiple non-incretin activities in the regulation of blood glucose, the primary action of GIP is the stimulation of glucose-dependent insulin secretion. GIP may also play a role in adipocyte biology and it seems to act to regulate body weight. GIP is rapidly inactivated both in vitro and in vivo by the dipeptidyl peptidase 4 (DPP-4), the enzyme which also cleaves GLP-1 and GLP-2, rapidly inactivates GIP. The majority of circulating GIP immunoreactivity in both the fasting and postprandial states corresponds to the biologically inactive GIP (amino acids 3-42).

Principle of Test Method:

The GIP assay is a solid-phase ELISA designed to measure human GIP in serum and plasma. It employs the quantitative sandwich enzyme immunoassay principle.

Download this assay page in pdf format.

GIP (Gastric Inhibitory Polypeptide)
back to top